These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 8387635)
1. Agonistic and antagonistic effects of cholera toxin on human B lymphocyte proliferation. Garrone P; Banchereau J Mol Immunol; 1993 May; 30(7):627-35. PubMed ID: 8387635 [TBL] [Abstract][Full Text] [Related]
2. Prostaglandin E2 promotes IL-4-induced IgE and IgG1 synthesis. Roper RL; Conrad DH; Brown DM; Warner GL; Phipps RP J Immunol; 1990 Oct; 145(8):2644-51. PubMed ID: 2170523 [TBL] [Abstract][Full Text] [Related]
3. cAMP-independent effects of cholera toxin on B cell activation. I. A possible role for cell surface ganglioside GM1 in B cell activation. Francis ML; Moss J; Fitz TA; Mond JJ J Immunol; 1990 Nov; 145(10):3162-9. PubMed ID: 2172379 [TBL] [Abstract][Full Text] [Related]
4. Characterization of the 3',5'-cyclic adenosine monophosphate-mediated regulation of IL2 production by T cells and Jurkat cells. Wacholtz MC; Minakuchi R; Lipsky PE Cell Immunol; 1991 Jul; 135(2):285-98. PubMed ID: 1709824 [TBL] [Abstract][Full Text] [Related]
5. Prostaglandin E2 and cAMP inhibit B lymphocyte activation and simultaneously promote IgE and IgG1 synthesis. Roper RL; Phipps RP J Immunol; 1992 Nov; 149(9):2984-91. PubMed ID: 1328389 [TBL] [Abstract][Full Text] [Related]
6. Different effect of prostaglandin E2 on B-cell activation by two distinct B-cell differentiation factors, B151-TRF1/IL-5 and B151-TRF2: selective inhibition of B151-TRF2-induced antibody response through increases in intracellular cyclic AMP levels. Ishihara K; Ono S; Takahama Y; Hirayama F; Hirano H; Itoh K; Dobashi K; Murakami S; Katoh Y; Yamaguchi M Immunology; 1989 Oct; 68(2):154-62. PubMed ID: 2553585 [TBL] [Abstract][Full Text] [Related]
7. Effects of cholera toxin on human B cells. Cholera toxin induces B cell surface DR expression while it inhibits anti-mu antibody-induced cell proliferation. Anastassiou ED; Yamada H; Francis ML; Mond JJ; Tsokos GC J Immunol; 1990 Oct; 145(8):2375-80. PubMed ID: 2120330 [TBL] [Abstract][Full Text] [Related]
8. Regulatory effects of prostaglandin E2 on the growth and differentiation of human B lymphocytes activated through their CD40 antigen. Garrone P; Galibert L; Rousset F; Fu SM; Banchereau J J Immunol; 1994 May; 152(9):4282-90. PubMed ID: 7512590 [TBL] [Abstract][Full Text] [Related]
9. Downregulation of JAK3 protein levels in T lymphocytes by prostaglandin E2 and other cyclic adenosine monophosphate-elevating agents: impact on interleukin-2 receptor signaling pathway. Kolenko V; Rayman P; Roy B; Cathcart MK; O'Shea J; Tubbs R; Rybicki L; Bukowski R; Finke J Blood; 1999 Apr; 93(7):2308-18. PubMed ID: 10090941 [TBL] [Abstract][Full Text] [Related]
10. Differential regulatory effects of cAMP-elevating agents on human normal and neoplastic B cell functional response following ligation of surface immunoglobulin and CD40. Kelly K; Knox KA Cell Immunol; 1995 Nov; 166(1):93-102. PubMed ID: 7585986 [TBL] [Abstract][Full Text] [Related]
11. Delineation of the mechanism of inhibition of human T cell activation by PGE2. Minakuchi R; Wacholtz MC; Davis LS; Lipsky PE J Immunol; 1990 Oct; 145(8):2616-25. PubMed ID: 1976699 [TBL] [Abstract][Full Text] [Related]
12. Modulation of IL-2- and IL-4-dependent human B cell proliferation by cyclic AMP. Vazquez A; Auffredou MT; Galanaud P; Leca G J Immunol; 1991 Jun; 146(12):4222-7. PubMed ID: 1645759 [TBL] [Abstract][Full Text] [Related]
13. Cholera toxin promotes the proliferation of anti-mu antibody-prestimulated human B cells. Anastassiou ED; Yamada H; Boumpas DT; Tsokos GC; Thyphronitis G; Balow J; Mond JJ Cell Immunol; 1992 Mar; 140(1):237-47. PubMed ID: 1310902 [TBL] [Abstract][Full Text] [Related]
14. Inhibition of murine lymphocyte proliferation by the B subunit of cholera toxin. Woogen SD; Ealding W; Elson CO J Immunol; 1987 Dec; 139(11):3764-70. PubMed ID: 2824614 [TBL] [Abstract][Full Text] [Related]
15. Differential regulation of surface immunoglobulin and Lyb2 mediated B cell activation: II. cAMP dependent (prostaglandin E2) and independent (IFN-gamma) mechanisms of regulation of B lymphocyte activation. Muthusamy N; Bondada S Int Immunol; 1993 Aug; 5(8):949-56. PubMed ID: 8398988 [TBL] [Abstract][Full Text] [Related]
16. Differential regulation of surface Ig- and Lyb2-mediated B cell activation by cyclic AMP. I. Evidence for alternative regulation of signaling through two different receptors linked to phosphatidylinositol hydrolysis in murine B cells. Muthusamy N; Baluyut AR; Subbarao B J Immunol; 1991 Oct; 147(8):2483-92. PubMed ID: 1717562 [TBL] [Abstract][Full Text] [Related]
17. cAMP-independent effects of cholera toxin on B cell activation. III. Cholera toxin A subunit-mediated ADP-ribosylation acts synergistically with ionomycin or IL-4 to induce B cell proliferation. Francis ML; Okazaki I; Moss J; Kurosky A; Pecanha LM; Mond JJ J Immunol; 1995 May; 154(10):4956-64. PubMed ID: 7730606 [TBL] [Abstract][Full Text] [Related]
18. Adenosine 3',5'-cyclic monophosphate (cAMP)-dependent inhibition of IL-5 from human T lymphocytes is not mediated by the cAMP-dependent protein kinase A. Staples KJ; Bergmann M; Tomita K; Houslay MD; McPhee I; Barnes PJ; Giembycz MA; Newton R J Immunol; 2001 Aug; 167(4):2074-80. PubMed ID: 11489990 [TBL] [Abstract][Full Text] [Related]
19. Elevation of 3'5' cyclic adenosine monophosphate alters CD3 and CD25 antigens expression in activated T lymphocytes. Iwaz J; Lafont S; Cordier G; Revillard JP J Clin Lab Immunol; 1989 Jun; 29(2):85-9. PubMed ID: 2561159 [TBL] [Abstract][Full Text] [Related]
20. Cholera toxin promotes B cell isotype switching by two different mechanisms. cAMP induction augments germ-line Ig H-chain RNA transcripts whereas membrane ganglioside GM1-receptor binding enhances later events in differentiation. Lycke NY J Immunol; 1993 Jun; 150(11):4810-21. PubMed ID: 8388421 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]